Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 10.16
+0.06 (0.54%)
Aug 7, 2026, 1:50 PM CET
Grifols Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7,421 | 7,524 | 7,212 | 6,592 | 6,064 | 4,933 |
Revenue Growth | -0.33% | 4.33% | 9.40% | 8.71% | 22.92% | -7.62% |
Gross Profit Gross Profit Growth | 2,804 | 2,919 | 2,847 | 2,483 | 2,214 | 1,963 |
Operating Income Operating Income Growth | 1,349 | 1,395 | 1,319 | 718 | 671.4 | 562.51 |
Net Income Net Income Growth | 452 | 402 | 157 | 42 | 185.04 | 188.73 |
Earnings Per Share EPS Growth | 0.66 | 0.59 | 0.23 | 0.06 | 0.27 | 0.28 |
EPS Growth | 46.08% | 156.52% | 283.33% | -77.78% | -2.49% | -69.23% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Biopharma Biopharma Growth | 6,481 | 6,487 | 6,143 | 5,558 | 5,005 | 3,815 |
Diagnostic Diagnostic Growth | 592.63 | 640 | 645 | 670 | 671.29 | 779.11 |
Bio Supplies Bio Supplies Growth | 135.38 | 154 | 216 | 160 | 146.08 | 115.81 |
Others Others Growth | 212.11 | 243 | 208 | 204 | 250.17 | 266.46 |
Total Total Growth | 7,421 | 7,524 | 7,212 | 6,592 | 6,064 | 4,933 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 537 | 849 | 1,004 | 646.05 | 580.24 | 2,685 |
Total Debt Total Debt Growth | 9,356 | 9,643 | 10,167 | 11,057 | - | 10,165 |
Net Cash (Debt) Net Cash Growth | -8,819 | -8,794 | -9,163 | -10,411 | 580.24 | -7,480 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -12.87 | -12.90 | -13.48 | -15.32 | 0.85 | -10.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,091 | 1,047 | 902 | 217 | -1.43 | 596.98 |
Capital Expenditures CapEx Growth | -274 | -265 | -233 | -224 | -283.8 | -247.37 |
Free Cash Flow Free Cash Flow Growth | 817 | 782 | 669 | -7 | -285.23 | 349.6 |
Free Cash Flow Growth | -1.99% | 16.89% | - | - | - | -57.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.79% | 38.80% | 39.48% | 37.67% | 36.51% | 39.78% |
Operating Margin | 18.18% | 18.54% | 18.29% | 10.89% | 11.07% | 11.40% |
Pretax Margin | 9.00% | 8.17% | 6.16% | 3.13% | 5.57% | 7.10% |
Profit Margin | 6.09% | 5.34% | 2.18% | 0.64% | 3.05% | 3.83% |
FCF Margin | 11.01% | 10.39% | 9.28% | -0.11% | -4.70% | 7.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | - | - | - | - | - |
Dividend Per Share Growth | -45.08% | - | - | - | - | - |
Dividend Yield | 2.94% | - | - | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.31 | 16.26 | 36.19 | 219.78 | 35.44 | 51.84 |
Forward PE | 9.96 | 11.66 | 10.93 | 16.95 | 12.71 | 15.88 |
P/FCF Ratio | 7.38 | 8.36 | 8.49 | - | - | 27.98 |
PS Ratio | 0.81 | 0.87 | 0.79 | 1.40 | 1.08 | 1.98 |